Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Koselugo“
Suchtreffer
Begriffe & Kennungen
Koselugo · 4.5 · Co-administration with a strong CYP2C19/moderate CYP3A4 inhibitor (200 mg fluconazole once daily for 4 days) i
Eintrag öffnenKoselugo · 4.5 · Co-administration with strong inhibitors of CYP3A4 (e.g., clarithromycin, grapefruit juice, oral ketoconazole)
Eintrag öffnenKoselugo · 4.5 · Co-administration with strong inhibitors of CYP3A4 (e.g., clarithromycin, grapefruit juice, oral ketoconazole)
Eintrag öffnenKoselugo · 4.5 · Concomitant use of erythromycin (moderate CYP3A4 inhibitor) or fluoxetine (strong CYP2C19/CYP2D6 inhibitor) is
Eintrag öffnenKoselugo · 4.5 · Concomitant use of erythromycin (moderate CYP3A4 inhibitor) or fluoxetine (strong CYP2C19/CYP2D6 inhibitor) is
Eintrag öffnenKoselugo · 4.5 · Concomitant use of strong CYP3A4 inducers (e.g., phenytoin, rifampicin, carbamazepine, St. John’s Wort) or mod
Eintrag öffnenKoselugo · 4.5 · Concomitant use of strong CYP3A4 inducers (e.g., phenytoin, rifampicin, carbamazepine, St. John’s Wort) or mod
Eintrag öffnenKoselugo · 4.5 · Effect of gastric acid reducing agents on selumetinib Selumetinib capsules do not exhibit pH dependent dissolu
Eintrag öffnenKoselugo · 4.5 · Effect of gastric acid reducing agents on selumetinib Selumetinib granules do not exhibit pH dependent dissolu
Eintrag öffnenKoselugo · 4.5 · If co-administration is unavoidable, patients should be carefully monitored for adverse events and the selumet
Eintrag öffnenKoselugo · 4.5 · If co-administration is unavoidable, patients should be carefully monitored for adverse events and the selumet
Eintrag öffnenKoselugo · 4.5 · Interaction studies have only been performed in healthy adults (aged ≥ 18 years).
Eintrag öffnenKoselugo · 4.5 · Interaction studies have only been performed in healthy adults (aged ≥ 18 years).
Eintrag öffnenKoselugo · 4.5 · TPGS is a P-gp inhibitor in vitro and it cannot be excluded that it may cause clinically relevant drug interac
Eintrag öffnenKoselugo · 4.5 · The effect of selumetinib on the exposure of oral contraceptives has not been evaluated. Therefore, use of an
Eintrag öffnenKoselugo · 4.5 · The effect of selumetinib on the exposure of oral contraceptives has not been evaluated. Therefore, use of an
Eintrag öffnenKoselugo · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenKoselugo · 4.6 Fertility, pregnancy and lactation · 2
Eintrag öffnenKoselugo · 4.8 Undesirable effects · 1
Eintrag öffnenKoselugo · 4.8 Undesirable effects · 2
Eintrag öffnen